Key result
The morphology-voltage-P wave duration (MVP) ECG score was identified as an independent predictive parameter for early left atrial dysfunction in hypertensive patients.
Why the study?
Recognition of subtle left atrial dysfunction in early stages of hypertension is essential, and this study investigated the relationship between the newly defined MVP ECG score and early left atrial dysfunction in hypertensive patients.
Does the MVP ECG score predict early left atrial dysfunction in hypertensive patients?
Cross-Sectional (n=89)
Does the MVP ECG score predict early left atrial dysfunction in hypertensive patients?
The MVP ECG score may serve as a novel, independent predictor for detecting early left atrial dysfunction in patients with hypertension.
MVP ECG score may flag early left atrial dysfunction in hypertension; leaves open need for prospective validation before clinical adoption.
OBJECTIVE: Left atrial (LA) function is an important predictor of adverse cardiovascular outcomes in patients with hypertension (HT). Therefore, recognition of subtle LA dysfunction in the early stages of HT is essential for controlling modifiable variables. Several electrocardiographic and echocardiographic parameters have been studied to show early LA dysfunction. The goal of this study was to investigate the relationship between newly defined morphology-voltage-P wave duration electrocardiography (MVP ECG) score and early LA dysfunction in hypertensive patients. MATERIALS AND METHODS: Eighty-nine hypertensive patients were included in this study. Based on speckle tracking echocardiography results, the patients were divided into two groups: 67 patients with normal LA function were included in Group 1, and 22 patients with abnormal LA function in Group 2. RESULTS: Age, diabetes mellitus history, duration of HT history, left ventricular mass index, E/Em, and MVP ECG score values were statistically significant between the two groups. Based on the results of the multivariate logistic regression test, duration of HT history, E/Em, and MVP ECG score were determined as independent predictive parameters for early LA dysfunction in hypertensive patients. CONCLUSION: In conclusion, MVP ECG score assessment could be a novel approach to detect early LA dysfunction in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Kahyaoğlu et al. (2021) conducted a cross-sectional in Hypertension (n=89). Morphology-voltage-P wave duration (MVP) ECG score was evaluated on Early left atrial dysfunction. The morphology-voltage-P wave duration (MVP) ECG score was identified as an independent predictive parameter for early left atrial dysfunction in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: